In Vivo Effects of Myeloablative Alkylator Therapy on Survival and Differentiation of MGMTP140K-Transduced Human G-CSF-Mobilized Peripheral Blood Cells-Reference-Cited by-同舟云学术

In Vivo Effects of Myeloablative Alkylator Therapy on Survival and Differentiation of MGMTP140K-Transduced Human G-CSF-Mobilized Peripheral Blood Cells

Published:2006-05 Issue:5 Volume:13 Page:1016-1026
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Cai Shanbao,Hartwell Jennifer R.,Cooper Ryan J.,Juliar Beth E.,Kreklau Emi,Abonour Rafat,Goebel W. Scott,Pollok Karen E.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference36 articles.

1. DNA repair defects in stem cell function and aging;Park;Annu. Rev. Med.,2005

2. Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs;Sorrentino;Nat. Rev. Cancer,2002

3. Clinical relevance of MGMT in the treatment of cancer;Gerson;J. Clin. Oncol.,2002

4. Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma;Quinn;J. Clin. Oncol.,2002

5. Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector;Sawai;Mol. Ther.,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model;PLOS ONE;2018-11-29

2. Lentiviral MGMTP140K-mediated in vivo selection employing a ubiquitous chromatin opening element (A2UCOE) linked to a cellular promoter;Biomaterials;2014-08

3. Efficiency and Safety of O6-Methylguanine DNA Methyltransferase (MGMTP140K)-MediatedIn VivoSelection in a Humanized Mouse Model;Human Gene Therapy;2014-02

4. Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chainnull Mice;Bone Marrow Research;2011-12-26

5. Humanized Bone Marrow Mouse Model as a Preclinical Tool to Assess Therapy-Mediated Hematotoxicity;Clinical Cancer Research;2011-04-12